Save the Date: Quarterly MISTIE III Safety Forum

Please save the date for our

Quarterly MISTIE III Safety Forum

To be held via webinar

Wednesday, September 16th, 1-2pm EDT


Registration link: https://attendee.gotowebinar.com/register/4448979556126173697



MISTIE III Surgical Summary and Lessons Learned

Heparin Use in MISTIE III

Click here for a video recording of the Safety Forum.



  4747 Hits
4747 Hits

Site Inservice Training Slides Available

Good news everyone! Inservice training slides are now available in the documents section under Training Files. These are specifically designed to give non-core team members at your site a quick but comprehensive overview of the trial. 


  4759 Hits
4759 Hits

MISTIE-ICES Trial Closed to Enrollments!

Earlier this month, on April 3, PI: Alan Hoffer and Coordinator: Val Cwiklinski at Case Western Reserve University Hospital enrolled the last MISTIE-ICES subject, therefore closing the trial to enrollments!  The MISTIE-ICES Trial opened in mid-2008 and has since enrolled 20 subjects across five centers: Barrow Neurological Institute, Case Western Reserve University Hospital, University of California, Los Angeles, University of California, San Diego and the University of Pittsburgh Medical Center.

The MISTIE-ICES Trial is the 3rdtier in Stage I of the MISTIE Trial.  The purpose of the MISTIE-ICES Trial is to determine the safety of using either endoscopic surgery (ICES) or a combination of minimally invasive surgery and clot lysis with rt-PA (MISTIE) to remove intracerebral hemorrhage.  The ICES arm is led by Drs. Paul Vespa and Neil Martin at the University of California, Los Angeles and Dr. Dan Hanley at Johns Hopkins University.

  8485 Hits
8485 Hits

MISTIE-3 Site Locations